BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 10773877)

  • 1. p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.
    Teixeira LT; Kiyokawa H; Peng XD; Christov KT; Frohman LA; Kineman RD
    Oncogene; 2000 Apr; 19(15):1875-84. PubMed ID: 10773877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
    Kineman RD; Teixeira LT; Amargo GV; Coschigano KT; Kopchick JJ; Frohman LA
    Endocrinology; 2001 Sep; 142(9):3764-73. PubMed ID: 11517152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
    Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
    Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of galectin-3 in pituitary tumors.
    Riss D; Jin L; Qian X; Bayliss J; Scheithauer BW; Young WF; Vidal S; Kovacs K; Raz A; Lloyd RV
    Cancer Res; 2003 May; 63(9):2251-5. PubMed ID: 12727847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical characterization of "hyperplasia-adenoma sequence" in the pituitaries of transgenic mice expressing a human growth hormone-releasing factor gene.
    Umemura S; Oda K; Utsunomiya H; Sanno N; Itoh J; Katakami H; Osamura RY
    Tokai J Exp Clin Med; 1995 Jul; 20(2):71-9. PubMed ID: 8797263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas.
    Bamberger CM; Fehn M; Bamberger AM; Lüdecke DK; Beil FU; Saeger W; Schulte HM
    Eur J Endocrinol; 1999 Mar; 140(3):250-5. PubMed ID: 10216521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
    Peng XD; Park S; Gadelha MR; Coschigano KT; Kopchick JJ; Frohman LA; Kineman RD
    Endocrinology; 2001 Mar; 142(3):1117-23. PubMed ID: 11181526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.
    Luque RM; Soares BS; Peng XD; Krishnan S; Cordoba-Chacon J; Frohman LA; Kineman RD
    Endocrinology; 2009 Jul; 150(7):3177-85. PubMed ID: 19342460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
    Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanin gene expression is increased in the anterior pituitary gland of the human growth hormone-releasing hormone transgenic mouse.
    Moore JP; Morrison DG; Hyde JF
    Endocrinology; 1994 May; 134(5):2005-10. PubMed ID: 7512494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galanin within the normal and hyperplastic anterior pituitary gland: localization, secretion, and functional analysis in normal and human growth hormone-releasing hormone transgenic mice.
    Moore JP; Cai A; Maley BE; Jennes L; Hyde JF
    Endocrinology; 1999 Apr; 140(4):1789-99. PubMed ID: 10098517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
    de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
    Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.
    Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ
    Oncogene; 2004 Jan; 23(4):905-13. PubMed ID: 14647411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
    Theodoropoulou M; Arzberger T; Gruebler Y; Jaffrain-Rea ML; Schlegel J; Schaaf L; Petrangeli E; Losa M; Stalla GK; Pagotto U
    J Endocrinol; 2004 Nov; 183(2):385-94. PubMed ID: 15531726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
    Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
    Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte growth factor (HGF) inhibits skeletal muscle cell differentiation: a role for the bHLH protein twist and the cdk inhibitor p27.
    Leshem Y; Spicer DB; Gal-Levi R; Halevy O
    J Cell Physiol; 2000 Jul; 184(1):101-9. PubMed ID: 10825239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secretagogues and the somatotrope: signaling and proliferation.
    Frohman LA; Kineman RD; Kamegai J; Park S; Teixeira LT; Coschigano KT; Kopchic JJ
    Recent Prog Horm Res; 2000; 55():269-90; discussion 290-1. PubMed ID: 11036941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
    Barbareschi M
    Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.